Intensive insulin therapy has been shown to reduce the risk of microvascular complications in the short-term and macrovascular complications after 10 years of post-trial follow-up in newly diagnosed patients with type 2 diabetes (2, –4). The gene discussed is INS; the disease is type 2 diabetes mellitus.